India’s Supreme Court Directs Patent Office To Review Roche's Valcyte Before Jan. 31

MUMBAI - India's Supreme Court has directed the Controller General of Patents, Designs and Trade Marks to finalize the patent validity of Roche's Valcyte (valganciclovir) before Jan. 31, 2009. Roche had filed a special leave petition that contested the Madras High Court's earlier decision that directed the Indian patent office to review the product patent granted to Valcyte in 2007